ESC 365 - Key comorbidities and laboratory findings: insights from first prospective, observational and Multi-Center Malaysia Heart Failure (MYHF) registry

ESC Professional Premium Access

Key comorbidities and laboratory findings: insights from first prospective, observational and Multi-Center Malaysia Heart Failure (MYHF) registry

Session: Special Populations

Topic: Epidemiology, Prognosis, Outcome

Speaker: Professor W. Wan Ahmad (Kuala Lumpur, MY)

Event: ESC Asia 2022 with APSC & AFC

Congress Presentation

About the speaker

Professor Wan Azman Wan Ahmad

University Malaya Medical Centre (UMMC), Kuala Lumpur (Malaysia)

0 follower

3 more presentations in this session

An updated meta-analysis: The effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in the mortality of hypertensive patients with confirmed COVID-19 infection

Speaker: Doctor M. Manalili (San Juan, PH)

HbA1c variability is associated with adverse outcomes in heart failure patients with and without diabetes

Speaker: Doctor Q. Ren (Hong Kong, HK)

Prevalence, mortality, and disability-adjusted-life-years resulting from aortic aneurysm burden and its association with the socio-demographic index in Asia, 1990-2019: Results from the GBD 2019

Speaker: Professor L. Gobolos (Abu Dhabi, AE)

Access the full session

Special Populations

Speakers: Professor W. Wan Ahmad, Doctor M. Manalili, Doctor Q. Ren, Professor L. Gobolos

About the event

ESC Asia 2022 with APSC & AFC

1 December - 3 December 2022

Sessions Presentations

Congress

ESC 365 is supported by